Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants-Reference-Cited by-同舟云学术

Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants

Published:2022-06-01 Issue:6 Volume:8 Page:938
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Terrero Gretel¹,Datta Jashodeep¹,Dennison Jessica¹,Sussman Daniel A.¹,Lohse Ines¹,Merchant Nipun B.¹,Hosein Peter J.¹

Affiliation:

1. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2791557/jamaoncology_terrero_2022_ld_220004_1661975716.80963.pdf

Reference6 articles.

1. Molecular profiling of patients with pancreatic cancer: initial results from the Know Your Tumor initiative.;Pishvaian;Clin Cancer Res,2018

2. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer.;Golan;N Engl J Med,2019

3. Pan-cancer analysis of BRCA1 and BRCA2 genomic alterations and their association with genomic instability as measured by genome-wide loss of heterozygosity.;Sokol;JCO Precis Oncol,2020

4. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.;Strickland;Oncotarget,2016

5. Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial.;O’Reilly;JAMA Oncol,2019

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer;Targeted Oncology;2024-08-10

2. Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer;Journal of the National Comprehensive Cancer Network;2024-07

3. Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancer;2024-05-18

4. Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies;Frontiers in Medicine;2024-03-21

5. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives;Expert Review of Clinical Pharmacology;2024-03-15